Veracyte
Veracyte is a global diagnostics company that develops and commercializes genomic tests to improve cancer diagnosis and treatment decisions.
- Locations
- Spain only
- Newest advert
- 27 days ago
Associate Marketing Director
About the company
Veracyte is a global diagnostics company that develops and commercializes genomic tests to improve cancer diagnosis and treatment decisions. Its portfolio includes the Afirma test for thyroid nodules, the Decipher tests for prostate and bladder cancer, and the Prosigna test for breast cancer recurrence risk. The company operates a CLIA-certified laboratory in San Francisco and has an international presence, including a laboratory in Spain, serving patients and providers worldwide.
For International Professionals
- Veracyte has a laboratory in Spain, likely in the Madrid area, which may offer opportunities for roles in lab operations, bioinformatics, and clinical affairs.
- The company's international presence means English is likely the primary working language, but Spanish language skills are valuable for local roles.
- Veracyte is a publicly traded company (NASDAQ: VCYT), providing financial stability and growth potential.
- The company focuses on cancer diagnostics, a rapidly evolving field, offering opportunities to work on cutting-edge genomic technologies.
- Spain's labor laws and benefits apply to local employees, including 30 calendar days of vacation and 16 weeks of paid maternity/paternity leave.
Offices in Spain
Company History
Veracyte, Inc. is a global diagnostics company that specializes in genomic tests for cancer, with a focus on thyroid, breast, and urologic cancers. Founded in 2008 and headquartered in San Francisco, California, the company has grown through strategic acquisitions, including the 2021 purchase of Decipher Biosciences, which expanded its urologic cancer portfolio. Veracyte operates internationally, with a significant presence in Europe, including a laboratory in Spain.